TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
| Revenue (Most Recent Fiscal Year) | $1.76M |
| Net Income (Most Recent Fiscal Year) | $-2.18M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 7.36 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.51 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -119.61% |
| Net Margin (Trailing 12 Months) | -114.07% |
| Return on Equity (Trailing 12 Months) | -7.86% |
| Return on Assets (Trailing 12 Months) | -5.46% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.64 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.64 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.37 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 11.57M |
| Free Float | 11.31M |
| Market Capitalization | $13.54M |
| Average Volume (Last 20 Days) | 0.06M |
| Beta (Past 60 Months) | 0.65 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.30% |
| Percentage Held By Institutions (Latest 13F Reports) | 30.74% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |